NORTHLANE CAPITAL PARTNERS
NORTHLANE CAPITAL PARTNERS is a Series C+ and buyout fund in the US writing $25M–$150M checks into Healthcare and business-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, business-services
- Check size
- $25M–$150M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2003
- Assets under management
- $799M
- Website
- northlanecapital.com
Thesis
Northlane Capital Partners (NCP) is a private equity firm founded in 2003, specializing in control buyouts of lower-middle-market companies within the healthcare and business services sectors. Headquartered in Bethesda, Maryland, the firm has invested over $1.6 billion. Their strategy involves partnering with motivated management teams of market-leading companies in high-growth, recession-resistant niches, prioritizing strong EBITDA and cash flow. NCP seeks companies with sustainable competitive advantages, attractive growth opportunities, strong financial performance, and experienced management. They typically acquire businesses from founders and smaller institutional investors, aiming to accelerate growth through their industry expertise and executive network. Investment criteria include an Enterprise Value between $50M and $350M, Equity Investments of $25M to $150M, and EBITDA from $5M to $30M. Their geographic focus is primarily the United States. Northlane Capital Partners III LP, their third fund, closed at $750 million, and the firm's total AUM is reported as $799 million, managing two funds. They also leverage an executive network for specialized expertise. The firm has achieved 2 IPOs and 26 acquisitions.
Common questions
Does NORTHLANE CAPITAL PARTNERS invest at the Series C+ stage?
Yes. NORTHLANE CAPITAL PARTNERS lists Series C+ and buyout among the stages it invests in.
What check size does NORTHLANE CAPITAL PARTNERS write?
NORTHLANE CAPITAL PARTNERS writes $25M–$150M checks.
Where does NORTHLANE CAPITAL PARTNERS invest?
NORTHLANE CAPITAL PARTNERS invests in the US.